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doi:10.1016/j.jds.2011.05.010Abstract Background/purpose: Platelet-rich fibrin (PRF) obtained by Choukroun’s technique
is a healing biomaterial that concentrates in a single autologous fibrin membrane, mostly of
platelets and cytokines from blood harvest, and without any artificial biochemical modifica-
tion. However, no data are presently available concerning the use of PRF for the treatment
of periodontal intrabony defects. This report was to present the clinical and radiographic
changes of a patient with periodontal intrabony defects treated with PRF.
Material and methods: The left mandibular first molar (#36) and left maxillary second molar
(#27) with intrabony defects were filled with PRF as the sole grafting material in a 38-year-
old female patient. The primary outcomes evaluated in this study included changes in probing
depth, attachment level, and radiographic bone density between baseline and 6 months post-
operatively.
Results: The results showed that the application of PRF as the sole grafting material in intrab-
ony defects exhibited pocket reduction and gain in clinical attachment after 3 months and
6 months. Using National institute of health program, the 6 months postoperative radiographic
density of images for #27 and #36 showed an increase of 1.6 and 1.3 fold compared with each
preoperative radiography, respectively.
Conclusions: From a clinical and radiologic point of view at 6 months after surgery, the use of
PRF as the sole grafting material seems to be an effective modality of regenerative treatment
for periodontal intrabony defects.
Copyright ª 2011, Association for Dental Sciences of the Republic of China. Published by
Elsevier Taiwan LLC. All rights reserved.of Dentistry, Chung Shan Medical University Hospital, No. 110, Chien-Kuo N. Road, Section 1, Taichung
x55011; fax: þ886 4 24759065.
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Figure 1 Radiographic shadows indicated that the infrabony
defects and the furcation invasions might be occurred at teeth
of #27 and #36.
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Periodontal regeneration is a multifactorial process and
requires an orchestrated sequence of biological events
including cell adhesion, migration, proliferation, and
differentiation.1 Significant progress in the understanding
of periodontal wound healing has been made. Although
complete regeneration of the periodontal attachment
apparatus, including bone, periodontal ligament, and
cementum is possible, it is still not predictable.2
The most positive outcome of periodontal regenerative
procedures in infrabony defects3e5 and furcations6,7 has been
achievedwithacombinationofbonegraftingandguided tissue
regeneration. Recently, polypeptide growth factors which are
biological mediators that have the ability to regulate cell
proliferation, chemotaxis, and differentiation have also been
investigated. As preliminary evidence for their potential
applications inperiodontalwoundhealing, severalpolypeptide
growth factors have been identified in the human periodontal
tissue by immunohistochemistry and in situ hybridization.1
Platelet-rich fibrin (PRF) described by Choukroun et al.8
is a second-generation platelet concentrate which allows
one to obtain fibrin membranes enriched with platelets and
growth factors, after starting from an anticoagulant-free
blood harvest without any artificial biochemical modifica-
tion. The PRF clot forms a strong natural fibrin matrix,
which concentrates almost all the platelets and growth
factors of the blood harvest9,10 and shows a complex
architecture as a healing matrix, including mechanical
properties no other platelet concentrate offers. It is an
autologous biomaterial, and not an improved fibrin glue.
Some clinical applications have been described in oral
maxillofacial surgery11e13 and in dental implantology.14,15
Recently, we first report that PRF can stimulate cell
proliferation of osteoblasts, gingival fibroblasts, and peri-
odontal ligament cells but suppress oral epithelial cell
growth.16 These cell type-specific actions of PRF may be
beneficial for periodontal regeneration. However, no data
are available on the use of PRF in the treatment of human
periodontal intrabony defects. In this report, we present
the clinical and radiographic changes of a patient using PRF
as the sole grafting material in the treatment of peri-
odontal infrabony defects and furcations.
Case report
A 38-year-old woman was referred to the Department of
Periodontics, Chung Shan Medical University Hospital withTable 1 Changes in clinical parameters of #36.
Tooth mobility Probing depth (mm)
DB B MB DL L
Baseline II 4 5 8 6 9
Presurgery II 4 5 7 5 8
Postoperation (3 mo) I 3 3 4 3 4
Postoperation (6 mo) 0 3 2 3 3 3
Changes in probing depth as measured from gingival margin. Chang
cementoenamel junction.
B Z buccal; DB Z distal buccal; DL Z distal lingual; L Z lingual; MBa complaint of periodontal disease. The patient was
healthy and had not taken any long-term anti-inflammatory
medication or antibiotics. After periodontal examination
and radiographic evaluation (Fig. 1), the diagnosis was
chronic periodontitis.17 The study protocol was approved by
the Institutional Review Board of Chung Shan Medical
University Hospital. The surgical procedure and possible
alternatives were discussed with the patient.
Initial therapy consisted of oral hygiene instructions,
which were repeated until the patient achieved an O’Leary
plaque score18 of 20% or below. Scaling and root planing of
the teeth were performed. Trauma from occlusion was
evaluated by examining the obvious presence of fremitus in
centric occlusion or in working or balancing excursions.
Four weeks following Phase I therapy, a periodontal re-
evaluation was performed to confirm the suitability of the
left mandibular first molar (#36) (Table 1) and maxillary
second molar (#27) (Table 2) for this periodontal surgical
study.
Blood samples were taken according to the PRF protocol
with a PC-02 table centrifuge and collection kits provided
by Process (Nice, France).13,15 Briefly, blood samples were
taken from the patient without an anticoagulant in 10-mL
glass-coated plastic tubes (Becton Dickinson Vacutainer,
Franklin Lakes, NJ, USA) and immediately centrifuged at
3000 rpm for 12 minutes. A fibrin clot formed in the middle
part of the tube, whereas the upper part contained acel-
lular plasma, and the bottom part contained red corpuscles
(Fig. 2A). The fibrin clot was easily separated from the
lower part of the centrifuged blood (Fig. 2B). The PRF clot
was gently pressed into a membrane with sterile dry gauze.
PRF membranes were minced as graft materials (Fig. 2C)
and trimmed as membranes (Fig. 2D).Gingival recession (mm) Attachment gain (mm)
ML DB B MB DL L ML DB B MB DL L ML
8 2 2 3 2 1 2
7 2 2 3 2 2 2 0 0 1 1 0 1
4 2 2 3 2 2 2 1 2 3 2 4 3
3 2 1 2 2 2 2 1 2 3 2 5 4
es in gingival recession and attachment level as measured from
Z mesial buccal; ML Z mesial lingual.
Table 2 Changes in clinical parameters of #27.
Tooth
mobility
Probing depth (mm) Gingival recession (mm) Attachment gain (mm)
DB B MB DL L ML DB B MB DL L ML DB B MB DL L ML
Baseline II 7 6 9 8 5 10 0 2 1 0 3 1
Presurgery II 6 5 8 7 5 9 1 3 1 0 3 2 0 0 1 1 0 0
Postoperation (3 mo) II 4 3 5 5 3 5 2 4 2 1 4 2 1 1 3 1 1 5
Postoperation (6 mo) I 3 3 4 5 3 4 2 3 1 1 4 2 2 2 4 1 1 5
Changes in probing depth as measured from gingival margin. Changes in gingival recession and attachment level as measured from
cementoenamel junction.
B Z buccal; DB Z distal buccal; DL Z distal lingual; L Z lingual; MB Z mesial buccal; ML Z mesial lingual.
Intrabony defects with PRF 183The procedures were performed using identical tech-
niques by one investigator. An intrasulcular incision was
made on the buccal and lingual aspect of the tooth of left
mandibular sextants being treated (Fig. 3A). A full thickness
flap was raised and the inner surface of the flap was
curetted to remove the epithelium and granulation tissue
(Fig. 3B). Root surfaces were thoroughly planed using hand
instruments and ultrasonic scalers for furcation areas. TheFigure 2 Preparation of platelet-rich fibrin (PRF). (A) PRF form
acellular plasma and the bottom part contained red corpuscles. (B)
centrifuged blood. (C) The PRF clot was gently pressed between 2
minced as a grafting material.left mandibular first molar demonstrated mesial intrabony
defect and a through-and-through furcation invasion
(Fig. 3B). After removing granulation tissue thoroughly,
mesial intrabony defect was found to extend to buccal and
lingual aspects (2e3 wall infrabony defect). Treatment of
the periodontal defects was shown in Figs. 4 and 5. Briefly,
minced PRF was applied to the defect walls and root
surfaces. The PRF was then tightly packed in the furcationed in the middle part of the tube. The upper part contained
The fibrin clot was easily separated from the lower part of the
layers of sterile dry gauze to form a membrane (D) PRF can be
Figure 3 The clinical pictures of left mandibular sextant. (A) Before surgery. (B) After flap reflection, mesial infrabony defect
and a through-and-through furcation invasion were noted at #36.
184 Y.-C. Chang et alarea using amalgam condensers to the vertical level cor-
responding to the roof of the furcation. In the horizontal
direction, the PRF was flushed with the bone present on the
most apical area of the furcation. The PRF membrane was
trimmed and adapted over the grafted defect and above
the cementoenamel junction. The flaps were repositionedFigure 4 Clinical application of platelet-rich fibrin (PRF) on the b
walls and root surfaces. (B) Minced PRF was tightly packed in the
osseous defects. (D) PRF membrane was adapted over the graftedto their presurgical levels and sutured with silk utilizing an
interrupted technique (Fig. 6A).
After the operation, the patient was prescribed systemic
antibiotics (cephalosporin 250 mg, qid. 3 days), non-
steroidal anti-inflammatory drugs (cataflam, 25 mg, qid.
3 days), and 0.12 % chlorhexidine rinse (twice a day foruccal aspect of #36. (A) Minced PRF was applied to the defect
furcation area. (C) PRF membrane was trimmed to cover the
defect and above the cementoenamel junction.
Figure 5 Clinical application of platelet-rich fibrin (PRF) on the lingual aspect of #36. (A) Intrabony defect and furcation invasion
were shown. (B) Minced PRF was tightly packed in the intrabony defect and furcation. (C) PRF membrane was trimmed to cover the
osseous defects. (D) PRF membrane was adapted over the grafted defect and above the cementoenamel junction.
Intrabony defects with PRF 1854weeks). Sutureswere removedafter 7 days. Clinical healing
was normal with neither infectious episodes nor untoward
clinical symptoms. The patient was seen at 1st week, 2nd
week, 1st month, 3rd month, and 6th month (Fig. 6B). During
the first 4 weeks, the patient was instructed to brush only
the non-involved teeth. Periodontal examinations wereFigure 6 The clinical pictures after platelet-rich fibrin application
sutured with silk utilizing an interrupted technique. (B) The clinicarecorded after 3 months and 6 months (Table 1) and peri-
apical radiography was taken after 6 months. The same
procedure was performed for #27. Postoperative clinical
parameters showed that the application of PRF for peri-
odontal osseous defects achieved probing depth reduction
and clinical attachment gain (Tables 1 and 2).. (A) The flaps were repositioned to their presurgical levels and
l picture of #36 3 months after operation.
186 Y.-C. Chang et alPeriapical intraoral radiographs were obtained from the
periodontal defect sites before and 6 months after surgery
(Figs. 7A and 8A). The radiographs were obtained with
a paralleling technique using the Rinn system, but no
attempts for further standardization were made. The
radiographic density of the images was analyzed by means
of the mathematical routine developed in the National
institute of health (NIH) program environment. For each
radiograph, a score from 0 to 100 was created, with the
value 0 being conferred on the most radiolucent area and
the value 100 on the most radiopaque area. The lesion area
and an adjacent bone area in each radiograph were also
cropped by means of the NIH program. 6 months after PRF
application, radiograph exhibited a significant increase
(Figs. 7B and 8B). Using the quantitative measurements by
the NIH program, the levels of the postoperative radio-
graphic density were 1.6- and 1.3 fold for #36 and #27
compared with each preoperative radiography,
respectively.Discussion
PRF by Choukroun’s technique is prepared naturally
without addition of thrombin, and it is hypothesized that
PRF has a natural fibrin framework and can protect growth
factors from proteolysis.19,20 Thus, growth factors can keep
their activity for a relatively longer period and stimulate
tissue regeneration effectively. PRF can be considered as
a natural fibrin-based biomaterial favorable to the devel-
opment of a microvascularization and able to guide cell
migration into wound area.
To the best of our knowledge, this is the first report
about the use of PRF as the sole grafting material for
periodontal intrabony defects and furcations. In this case
report, the reduction in pocket depth and gain in clinical
attachment were found after PRF application. Pocket
depth reduction is not only a desirable outcome of peri-
odontal regenerative procedures, but may also be the most
important parameter in patient care for the clinician,
because it directly impacts one’s ability to instrument
a treated area during maintenance appointments. An
important clinical outcome of a periodontal regenerative
procedure is gain in clinical attachment. This gain in clinicalFigure 7 The periapical radiography of #36. (A) preoperatively an
by the National institute of health program, the level of the po
radiography.attachment might have been a result of true periodontal
regeneration by means of new attachment or, alternatively,
of healing by repair, which implies the presence of a long
junctional epithelium between the newly regenerated
tissues and the root surface.21
PRF application exhibited the radiographic intensity
increase by periapical radiography after 6 months over
lesion areas. Radiographic evaluation is a noninvasion
examination for bony defects repair. However, bone fill
data derived from surgical re-entry are important to
substantiate routine postoperative measurement data.
Furthermore, histology of the treated periodontal osseous
defects is the only reliable method to determine the nature
of the periodontal soft and hard tissue interface.
The reason why PRF could improve periodontal osseous
defects healing may be explained as follows. Recently, we
found that PRF can upregulate phosphorylated extracel-
lular signal-regulated protein kinase expression and
suppress osteoclastogenesis by promoting the secretion of
osteoprotegerin in osteoblasts cultures.22 PRF was also
demonstrated to stimulate osteogenic differentiation of
human dental pulp cells by upregulating osteoprotegerin
and alkaline phosphatase expression.23 Furthermore, many
growth factors such as platelet-derived growth factor and
transforming growth factor are released from PRF.9,10,15,16
Recently, studies have demonstrated that the PRF
membrane has a very significant slow-sustained release of
key growth factors for at least 7days15 and up to 28 days,16
which means that the PRF membrane stimulates its envi-
ronment for a significant time during remodeling. The
properties of this natural fibrin biomaterial thus offer great
potential during wound healing. It has been clearly
demonstrated that fibrin matrix leads directly to angio-
genesis.14 Fibrin constitutes a natural support to immunity
and reduce inflammatory process.10 PRF itself can be
recognized as an autologous biomaterial. PRF, as membrane
and grafting material, offers an improved spacemaking
effect of the barrier, which is conducive to cell events
leading to periodontal regeneration, and facilitation of
mineralized tissue formation due to osteoconductive and/
or osteoinductive properties possibly inherent in PRF.
The acrylic stent, surgical re-entry, and digital radiog-
raphy are necessary to evaluate for further assessment of
PRF outcome for periodontal regeneration. A limitation ofd (B) 6 months postoperatively. The quantitative measurement
stoperative density was 1.6 fold compared with preoperative
Figure 8 The periapical radiography of #27. (A) preoperatively and (B) 6 months postoperatively. The quantitative measurement
by the National institute of health program, the level of the postoperative density was 1.3 fold compared with preoperative
radiography.
Intrabony defects with PRF 187the present study is the 6-month follow-up time, which
could be regarded as rather short, especially for the eval-
uation of osseous changes. Furthermore, because case
report(s) and case series were performed without a control
group, the interpretation is only based on observation of
the relevant case(s). The parallel observation on contra-
lateral periodontal intrabony defects without PRF as
a control should be performed in future to specify the
advantages of this method in periodontal regeneration.
PRF by Choukroun’s technique is a simple and inexpen-
sive technique, and the systematic use of this biomaterial
for periodontal regeneration seems a very promising
option. This case report demonstrates that the use of PRF,
as the sole grafting material in periodontal osseous defects,
is an effective modality in promoting a clinical resolution.
The practical aspect of PRF use in periodontal osseous
defects may be clinically relevant. Because PRF prepara-
tion utilizes the patient’s own blood, the risk of human to
human/animal disease transmission is virtually eliminated,
making it a safe treatment modality. The application of PRF
for periodontal osseous defects achieves probing depth
reduction, clinical attachment gain, and intensity increase
of periapical radiography over a 6-month period. Thus, PRF,
as a natural and optimized blood clot, seemed the
adequate adjuvant to secure this technique and to improve
the guided tissue regeneration.References
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